Dorzagliatin (HMS-5552, RO-5305552, Sinogliatin) is a dual-acting glucokinase (GK) activator that improves glycaemic control and pancreatic β-cell function in patients with type 2 diabetes.
[1] Xiao-Xue Zhu, et al. Diabetes Obes Metab. 2018 Sep;20(9):2113-2120.
















